Reata Pharmaceuticals, Inc. - Class A Common Stock (NQ:RETA)

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, Sep 25, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Reata Pharmaceuticals, Inc. - Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

13 14 Next >

12 Health Care Stocks Moving In Monday's Intraday Session ↗

February 27, 2023

Via Benzinga

Why CVRx Shares Are Trading Lower By 43%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

February 21, 2023

Gainers Arbe Robotics Ltd. (NASDAQ: ARBE) gained 62.8% to $7.08. Arbe Robotics is expected to report its financial results for the fourth quarter on Thursday, March 2, 2023.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

February 21, 2023

Via Benzinga

Looking Into Reata Pharmaceuticals's Return On Capital Employed ↗

December 05, 2022

Via Benzinga

Analyst Ratings for Reata Pharmaceuticals ↗

November 28, 2022

Via Benzinga

Why Reata Pharmaceuticals Stock Is Soaring Today ↗

November 08, 2022

Investors are cheering the company's third-quarter update.

Via The Motley Fool

The Nasdaq Is Rebounding: 2 Supercharged Growth Stocks to Buy in February ↗

February 01, 2023

These two growth stocks might deliver enormous gains for shareholders this month.

Via The Motley Fool

February PDUFA Catalysts Biotech Investors Must Know: Sanofi's Bleeding Disorder Drug, Regeneron's Twin Eylea Label Expansions, 3 Delayed Approvals And More ↗

January 31, 2023

The year has started well for biopharma companies on the regulatory front, as most decisions handed out during January were positive. The Food and Drug Administration has already cleared four new...

Via Benzinga

Reata Pharmaceuticals To Jump 220%? Plus JP Morgan Predicts $51 For Las Vegas Sands ↗

November 28, 2022

Goldman Sachs boosted the price target on Reata Pharmaceuticals, Inc. (NASDAQ: RETA) from $86 to $115. Goldman Sachs analyst Madhu Kumar maintained the stock with a Buy rating. Reata Pharmaceuticals...

Via Benzinga

Reata Pharmaceuticals Announces Participation in the Guggenheim 2022 Immunology and Neurology Conference and the Stifel 2022 Healthcare Conference

November 10, 2022

From Reata Pharmaceuticals, Inc.

Via Business Wire

Planet Fitness To Surge Over 25%? Plus Morgan Stanley Cuts PT On This Stock By 50% ↗

November 09, 2022

Raymond James raised the price target on Planet Fitness, Inc. (NYSE: PLNT) from $70 to $84. Raymond James analyst Joseph Altobello maintained a Strong Buy rating on the stock. Planet Fitness shares...

Via Benzinga

DuPont, Expeditors International, Planet Fitness And Other Big Gainers From Tuesday ↗

November 09, 2022

U.S. stocks closed higher on Tuesday, with the Dow Jones surging more than 300 points. Here is the list of some big stocks recording gains in the previous session.

Via Benzinga

Reata Pharmaceuticals, Inc. Announces Third Quarter 2022 Financial Results and Provides an Update on Clinical Development Programs

November 08, 2022

From Reata Pharmaceuticals, Inc.

Via Business Wire

Why Party City Holdco Shares Tumbled Over 40%; Here Are 98 Biggest Movers From Yesterday ↗

November 09, 2022

Gainers Unique Fabricating, Inc. (NYSE: UFAB) jumped 56.3% to close at $0.8205 on Tuesday. Unique Fabricating posted a Q3 loss of $0.90 per share after the closing bell on Tuesday.

Via Benzinga

Why TaskUs Shares Are Trading Higher By 37%? Here Are 77 Stocks Moving In Tuesday's Mid-Day Session ↗

November 08, 2022

Gainers IceCure Medical Ltd (NASDAQ: ICCM) shares jumped 39.4% to $1.4529 after the company announced a payment assignment from the Centers for Medicare & Medicaid Services for the ProSense breast...

Via Benzinga

Reata Pharmaceuticals, Inc. to Report Third Quarter 2022 Financial Results and to Provide an Update on Clinical Development Programs on November 8, 2022

October 31, 2022

From Reata Pharmaceuticals, Inc.

Via Business Wire

2 On-Fire Biotech Stocks That Are Crushing the Bear Market ↗

October 31, 2022

The biotech sector is down this year, but these two biopharmaceutical stocks have delivered strong returns.

Via The Motley Fool

Reata Pharmaceuticals Announces Presentations at the International Congress for Ataxia Research 2022

October 20, 2022

From Reata Pharmaceuticals, Inc.

Via Business Wire

Dow Dips 375 Points; S&P 500 Down Over 2% ↗

October 14, 2022

U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping around 375 points on Friday.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 19, 2022 ↗

October 19, 2022

Upgrades

Via Benzinga

Why Minerva Neurosciences Shares Dipped By Around 70%; Here Are 90 Biggest Movers From Yesterday ↗

October 18, 2022

Gainers Acorda Therapeutics, Inc. (NASDAQ: ACOR) surged 163.8% to close at $0.8970 on Monday after the company announced a $16.5 million award and royalty/supply relief in the AMPYRA arbitration case.

Via Benzinga

Why Laser Photonics Shares Surged By Around 19%; Here Are 70 Biggest Movers From Friday ↗

October 17, 2022

Gainers Agrify Corporation (NASDAQ: AGFY) climbed 53.8% to close at $1.45. FedNat Holding Company (NASDAQ: FNHC) gained 48% to settle at $0.52.

Via Benzinga

Why Is Reata Pharmaceuticals (RETA) Stock Up 15% Today? ↗

October 14, 2022

The FDA will not hold a meeting to review Reata Pharmaceuticals’ therapeutic for a rare disorder yet RETA stock soared. Here’s why.

Via InvestorPlace

12 Health Care Stocks Moving In Friday's Intraday Session ↗

October 14, 2022

Gainers

Via Benzinga

Why Morgan Stanley Shares Are Trading Lower, Here Are 43 Stocks Moving In Friday's Mid-Day Session ↗

October 14, 2022

Gainers Intelligent Living Application Group Inc. (NASDAQ: ILAG) surged 77.7% to $9.35.

Via Benzinga

Nasdaq Tumbles Over 200 Points; Crude Oil Falls Sharply ↗

October 14, 2022

U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping more than 200 points on Friday.

Via Benzinga

US Stocks Open Lower; Dow Drops Over 100 Points ↗

October 14, 2022

U.S. stocks traded lower this morning, with the Dow Jones dropping more than 100 points on Friday.

Via Benzinga

Reata Pharmaceuticals Announces that the FDA Does Not Plan to Hold an Advisory Committee Meeting to Discuss the NDA for Omaveloxolone for Friedreich’s Ataxia

October 13, 2022

From Reata Pharmaceuticals, Inc.

Via Business Wire

Reata Pharmaceuticals Announces Participation in the Citi 17th Annual BioPharma Conference

September 06, 2022

From Reata Pharmaceuticals, Inc.

Via Business Wire

Why IMARA Jumped Around 75%; Here Are 54 Biggest Movers From Yesterday ↗

September 08, 2022

Gainers

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9

...

13 14 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.